Iradimed (NASDAQ:IRMD) Updates FY 2024 Earnings Guidance
Iradimed (NASDAQ:IRMD – Get Free Report) updated its FY 2024 earnings guidance on Thursday. The company provided earnings per share guidance of 1.640-1.670 for the period, compared to the consensus earnings per share estimate of 1.560. The company issued revenue guidance of $72.7 million-$73.1 million, compared to the consensus revenue estimate of $72.6 million. Iradimed […]
More Stories
Birchcliff Energy Ltd. (OTCMKTS:BIREF) Short Interest Up 5.6% in November
Birchcliff Energy Ltd. (OTCMKTS:BIREF – Get Free Report) was the target of a significant growth in short interest in November....
ASSA ABLOY AB (publ) (OTCMKTS:ASAZF) Sees Large Growth in Short Interest
ASSA ABLOY AB (publ) (OTCMKTS:ASAZF – Get Free Report) was the target of a large increase in short interest in...
Janus Henderson Group PLC Buys 33,193 Shares of American Express (NYSE:AXP)
Janus Henderson Group PLC lifted its holdings in shares of American Express (NYSE:AXP) by 0.8% in the 3rd quarter, Holdings...
Insight Holdings Group LLC Acquires 32,900 Shares of Broadcom Inc. (NASDAQ:AVGO)
Insight Holdings Group LLC lifted its position in Broadcom Inc. (NASDAQ:AVGO – Free Report) by 940.0% during the 3rd quarter,...
Life360 (NASDAQ:LIF) Reaches New 12-Month High Following Analyst Upgrade
Life360, Inc. (NASDAQ:LIF – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Tuesday after...
Revolution Medicines (NASDAQ:RVMD) Stock Price Expected to Rise, Guggenheim Analyst Says
Revolution Medicines (NASDAQ:RVMD – Get Free Report) had its target price increased by Guggenheim from $82.00 to $87.00 in a...